83
Views
14
CrossRef citations to date
0
Altmetric
Review

Activation of type I interferon in systemic lupus erythematosus

, &
Pages 579-588 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Iris L. A. Bodewes & Marjan A. Versnel. (2018) Interferon activation in primary Sjögren’s syndrome: recent insights and future perspective as novel treatment target. Expert Review of Clinical Immunology 14:10, pages 817-829.
Read now

Articles from other publishers (13)

Peter E Lipsky, Ronald van Vollenhoven, Thomas Dörner, Victoria P Werth, Joan T Merrill, Richard Furie, Milan Petronijevic, Benito Velasco Zamora, Maria Majdan, Fedra Irazoque-Palazuelos, Robert Terbrueggen, Nikolay Delev, Michael Weiswasser, Shimon Korish, Mark Stern, Sarah Hersey, Ying Ye, Allison Gaudy, Zhaohui Liu, Robert Gagnon, Shaojun Tang & Peter H Schafer. (2022) Biological impact of iberdomide in patients with active systemic lupus erythematosus. Annals of the Rheumatic Diseases 81:8, pages 1136-1142.
Crossref
Gantsetseg Tumurkhuu, Shuang Chen, Erica N. Montano, Duygu Ercan Laguna, Gabriela De Los Santos, Jeong Min Yu, Malcolm Lane, Michifumi Yamashita, Janet L. Markman, Luz P. Blanco, Mariana J. Kaplan, Kenichi Shimada, Timothy R. Crother, Mariko Ishimori, Daniel J. Wallace, Caroline A. Jefferies & Moshe Arditi. (2020) Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-Induced Lupus Model. Frontiers in Immunology 11.
Crossref
Yong-Ling He, Jun Yang, Zhi-Neng Zeng & Xiang Shi. (2020) Interaction of miR-181b and IFNA1 Polymorphisms on the Risk of Systemic Lupus Erythematosus . BioMed Research International 2020, pages 1-7.
Crossref
Adrianos Nezos, Fotini Gravani, Anna Tassidou, Efstathia K. Kapsogeorgou, Michael Voulgarelis, Michael Koutsilieris, Mary K. Crow & Clio P. Mavragani. (2015) Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis. Journal of Autoimmunity 63, pages 47-58.
Crossref
Haralampos M. Moutsopoulos. (2014) Sjögren's syndrome: A forty-year scientific journey. Journal of Autoimmunity 51, pages 1-9.
Crossref
Veronica Rodriguez-Garcia, Sofia Sapeta Dias & David Isenberg. (2014) Recent advances in the treatment of systemic lupus erythematosus. International Journal of Clinical Rheumatology 9:1, pages 89-100.
Crossref
Kyriakos A. Kirou & Elena Gkrouzman. (2013) Anti-interferon alpha treatment in SLE. Clinical Immunology 148:3, pages 303-312.
Crossref
Yihong Yao, Zheng Liu, Bahija Jallal, Nan Shen & Lars Rönnblom. (2013) Type I interferons in Sjögren's syndrome. Autoimmunity Reviews 12:5, pages 558-566.
Crossref
A Becker-Merok, G Østli-Eilersten, S Lester & JC Nossent. (2012) Circulating interferon-α2 levels are increased in the majority of patients with systemic lupus erythematosus and are associated with disease activity and multiple cytokine activation. Lupus 22:2, pages 155-163.
Crossref
Elizabeth Schulman, Kun Chen, Gregory Saboeiro, Abraham Sanders, Kyriakos Kirou, Robert F. Spiera, Anne R. Bass & Doruk Erkan. (2010) Cyclophosphamide Responsive Interstitial Lung Disease in “Overlap Syndrome”. HSS Journal 7:1, pages 99-105.
Crossref
Clio P. Mavragani & Mary K. Crow. (2010) Activation of the type I interferon pathway in primary Sjogren’s syndrome. Journal of Autoimmunity 35:3, pages 225-231.
Crossref
Clio P. Mavragani & Haralampos M. Moutsopoulos. (2010) The geoepidemiology of Sjögren's syndrome. Autoimmunity Reviews 9:5, pages A305-A310.
Crossref
Jessica K. Gordon, Cynthia Magro, Theresa Lu, Robert Schneider, April Chiu, Richard R. Furman, Garron Solomon, Anne Bass & Doruk Erkan. (2009) Overlap between Systemic Lupus Erythematosus and Kikuchi Fujimoto Disease. HSS Journal®: The Musculoskeletal Journal of Hospital for Special Surgery 5:2, pages 169-177.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.